Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
56,45 USD | -0,05% | +1,07% | +25,64% |
08/03 | Novo Nordisk hoopt experimenteel medicijn tegen zwaarlijvigheid dit decennium te kunnen lanceren | RE |
07/03 | Transcript : Catalent, Inc. - Special Call |
Omzet 2024 * | 4,38 mld. 4,06 mld. | Omzet 2025 * | 4,67 mld. 4,33 mld. | Marktkapitalisatie | 10,2 mld. 9,46 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -825 mln. -765 mln. | Nettowinst (verlies) 2025 * | 89 mln. 82,52 mln. | EV/omzet 2024 * | 3,43 x |
Nettoschuld 2024 * | 4,8 mld. 4,45 mld. | Nettoschuld 2025 * | 4,5 mld. 4,17 mld. | EV/omzet 2025 * | 3,15 x |
K/w-verhouding 2024 * |
-12,4
x | K/w-verhouding 2025 * |
114
x | Werknemers | 17.800 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,1% |
Recentste transcriptie over Catalent, Inc.
1 dag | -0,05% | ||
1 week | +1,07% | ||
Lopende maand | -1,55% | ||
1 maand | -2,57% | ||
3 maanden | +23,96% | ||
6 maanden | +23,50% | ||
Lopend jaar | +25,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 52 | 01-10-10 | |
Matti Masanovich
DFI | Director of Finance/CFO | 52 | 05-07-23 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | 01-08-14 |
John Greisch
CHM | Chairman | 68 | 16-02-18 |
J. Carroll
BRD | Director/Board Member | 74 | 28-07-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.35% | 2 M€ | -.--% | ||
1.21% | 8 M€ | +6,91% | ||
0.83% | 2 M€ | +12,97% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 56,45 | -0,05% | 1 841 407 |
27-03-24 | 56,48 | +0,39% | 1 591 837 |
26-03-24 | 56,26 | -0,25% | 1 721 252 |
25-03-24 | 56,4 | +1,09% | 1 695 499 |
22-03-24 | 55,79 | -0,11% | 1 127 189 |
uitgestelde koers Nyse, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,64% | 10,21 mld. | |
+33,46% | 701 mld. | |
+26,24% | 571 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,61% | 157 mld. |